Furthermore, the combination of PTX and SETDB1 inhibition leads to increased expression of FosB, a transcription factor linked to cell proliferation, suggesting that SETDB1‐mediated regulation of FosB may play a role in cancer progression during chemotherapy61 (Figure 3). This evidence concerns the gene SETDB1 and cancer.